Olanzapine-associated neuroleptic malignant syndrome

Pharmacotherapy

Volumn 26, Issue 8 I, 2006, Pages 1180-1182

  Norgard, Nick B ^a   Stark, Jennifer E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

Author keywords

Atypical antipsychotics; Neuroleptic malignant syndrome; NMS; Olanzapine

Indexed keywords

AMOXICILLIN; BENZATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CREATINE KINASE; DANTROLENE; DONEPEZIL; HALOPERIDOL; LEVOFLOXACIN; LORAZEPAM; METOPROLOL; MIRTAZAPINE; OLANZAPINE; PIPERACILLIN PLUS TAZOBACTAM; QUETIAPINE; RISPERIDONE; TRAZODONE; VALPROIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HYPERTENSION; LEUKOCYTOSIS; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PARANOID SCHIZOPHRENIA;

AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA, PARANOID;

EID: 33746771436     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.8.1180     Document Type: Article

References (9)

1. Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth 2000;85:129-35.
2. Reeves RR, Torres RA, Liberto V, Hart RH. Atypical neuroleptic malignant syndrome associated with olanzapine. Pharmacotherapy 2002;22:641-4.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed, text revision. Washington, DC: American Psychiatric Association, 2000.
4. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-45.
5. Lazarus A, Mann SC, Caroff SN. The neuroleptic malignant . syndrome and related conditions. Washington, DC: American Psychiatric Press, 1989.
6. Keck PE Jr, Pope HG Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome: a prospective study. Am J Psychiatry 1987;144:1344-6.
7. Kontaxakis VP, Havaki-Kontaxaki BJ, Christodoulou NG, Paplos KG. Olanzapine-associated neuroleptic malignant syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:897-902.
8. Karagianis J, Phillips L, Hogan K, LeDrew K. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature. Ann Pharmacother 1999;33:623-30.
9. Kogoj A, Velikonja I. Olanzapine-induced neuroleptic malignant syndrome: a case review. Hum Psychopharmacol 2003;18:301-9.